Immune to Cancer: The CRI Blog
-
Cancer Immunotherapy: The Year in Review and a Look at the Year Ahead
Dr. Elizabeth Jaffee highlights 2018’s advances and 2019’s potential breakthroughs in cancer treatment
-
Learning from a Courageous Dog with Cancer
Francesca Pearson organized a Facebook fundraiser in memory of her dog Bosch.
-
How Immunotherapy Is Making an Impact in Liver Cancer
We spoke with Bruno Sangro, MD, PhD, about the current treatment landscape for patients with liver cancer,…
-
Six CRI-Funded Scientists on Dr. James P. Allison’s Impact on Their Lives and Careers
We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact…
-
David’s Immunotherapy Story
Melanoma | Diagnosed 2014 I am not a statistic. David’s Story Melanoma, that word had always been terrifying… -
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…
-
Voices Amongst the Crowd at 2018 TCS New York City Marathon
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an…
-
Fundraising and Fighting Cancer with Music for a Cause
On September 28, 2018, Conversing with Oceans organized a concert and fundraiser in the Bronx to support…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.